Metelimumab
Metelimumab (CAT-192) is a human IgG4 monoclonal antibody that can selectively neutralize TGFβ1[1].
Product Specifications
CAS Number
[272780-74-2]
Product Name Alternative
CAT-192; Anti-TGFB1 Recombinant Antibody
UNSPSC
12352203
Target
TGF-β Receptor
Type
Inhibitory Antibodies
Related Pathways
TGF-beta/Smad
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/metelimumab.html
Purity
98.98
Solubility
H2O
Smiles
[Metelimumab]
Molecular Weight
(145.02 kDa)
References & Citations
[1]Lord DM, et, al. Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibody. MAbs. 2018 Apr;10 (3) :444-452.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
124734-ML405 100 µL
CDC25A (M-phase Inducer Phosphatase 1, Dual Specificity Phosphatase Cdc25A) (MaxLight 405) discontinued
Sign In for Pricing
View Details MR225452L4V 200 µL
Pirb (NM_011095) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details